Phibro Animal Health annual gross margin
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Phibro Animal Health's gross margin was 30.85% for fiscal 2025.
View full Phibro Animal Health company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | 30.85% | +0.09 pp |
| 2024 | 2024-06-30 | 30.77% | +0.27 pp |
| 2023 | 2023-06-30 | 30.50% | +0.21 pp |
| 2022 | 2022-06-30 | 30.29% | −2.28 pp |
| 2021 | 2021-06-30 | 32.56% | +0.47 pp |
| 2020 | 2020-06-30 | 32.10% | +0.14 pp |
| 2019 | 2019-06-30 | 31.96% | −0.59 pp |
| 2018 | 2018-06-30 | 32.55% | +0.07 pp |
| 2017 | 2017-06-30 | 32.48% | +0.67 pp |
| 2016 | 2016-06-30 | 31.81% | +0.64 pp |
| 2015 | 2015-06-30 | 31.16% | +1.62 pp |
| 2014 | 2014-06-30 | 29.54% | +2.14 pp |
| 2013 | 2013-06-30 | 27.40% | +2.31 pp |
| 2012 | 2012-06-30 | 25.09% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-03-31 | 32.77% | +2.70 pp |
| Q2 2026 | 2025-12-31 | 35.48% | +2.54 pp |
| Q1 2026 | 2025-09-30 | 32.92% | +0.86 pp |
| Q4 2025 | 2025-06-30 | 29.05% | −2.85 pp |
| Q3 2025 | 2025-03-31 | 30.06% | −0.18 pp |
| Q2 2025 | 2024-12-31 | 32.94% | +1.49 pp |
| Q1 2025 | 2024-09-30 | 32.06% | +2.79 pp |
| Q4 2024 | 2024-06-30 | 31.90% | +1.84 pp |
| Q3 2024 | 2024-03-31 | 30.24% | −0.51 pp |
| Q2 2024 | 2023-12-31 | 31.45% | −0.18 pp |
| Q1 2024 | 2023-09-30 | 29.27% | −0.25 pp |
| Q4 2023 | 2023-06-30 | 30.06% | −0.66 pp |
| Q3 2023 | 2023-03-31 | 30.75% | +0.86 pp |
| Q2 2023 | 2022-12-31 | 31.63% | +1.26 pp |
| Q1 2023 | 2022-09-30 | 29.52% | −0.61 pp |
| Q4 2022 | 2022-06-30 | 30.72% | −0.98 pp |
| Q3 2022 | 2022-03-31 | 29.89% | −2.78 pp |
| Q2 2022 | 2021-12-31 | 30.37% | −2.75 pp |
| Q1 2022 | 2021-09-30 | 30.13% | −2.72 pp |
| Q4 2021 | 2021-06-30 | 31.70% | −0.88 pp |
| Q3 2021 | 2021-03-31 | 32.67% | −0.34 pp |
| Q2 2021 | 2020-12-31 | 33.11% | +0.82 pp |
| Q1 2021 | 2020-09-30 | 32.85% | +2.46 pp |
| Q4 2020 | 2020-06-30 | 32.58% | +0.55 pp |
| Q3 2020 | 2020-03-31 | 33.00% | +1.47 pp |
| Q2 2020 | 2019-12-31 | 32.29% | +0.83 pp |
| Q1 2020 | 2019-09-30 | 30.39% | −2.48 pp |
| Q4 2019 | 2019-06-30 | 32.03% | +0.15 pp |
| Q3 2019 | 2019-03-31 | 31.53% | −1.53 pp |
| Q2 2019 | 2018-12-31 | 31.46% | −1.05 pp |
| Q1 2019 | 2018-09-30 | 32.88% | +0.11 pp |
| Q4 2018 | 2018-06-30 | 31.88% | −0.52 pp |
| Q3 2018 | 2018-03-31 | 33.06% | +1.13 pp |
| Q2 2018 | 2017-12-31 | 32.50% | −0.64 pp |
| Q1 2018 | 2017-09-30 | 32.77% | +0.32 pp |
| Q4 2017 | 2017-06-30 | 32.40% | +0.91 pp |
| Q3 2017 | 2017-03-31 | 31.93% | −0.12 pp |
| Q2 2017 | 2016-12-31 | 33.14% | +1.09 pp |
| Q1 2017 | 2016-09-30 | 32.45% | +0.81 pp |
| Q4 2016 | 2016-06-30 | 31.49% | +0.26 pp |
| Q3 2016 | 2016-03-31 | 32.04% | +0.52 pp |
| Q2 2016 | 2015-12-31 | 32.05% | +2.33 pp |
| Q1 2016 | 2015-09-30 | 31.64% | −0.54 pp |
| Q4 2015 | 2015-06-30 | 31.23% | +3.51 pp |
| Q3 2015 | 2015-03-31 | 31.53% | +1.03 pp |
| Q2 2015 | 2014-12-31 | 29.72% | +0.11 pp |
| Q1 2015 | 2014-09-30 | 32.18% | +1.66 pp |
| Q4 2014 | 2014-06-30 | 27.71% | −0.41 pp |
| Q3 2014 | 2014-03-31 | 30.50% | — |
| Q2 2014 | 2013-12-31 | 29.61% | — |
| Q1 2014 | 2013-09-30 | 30.52% | — |
| Q3 2013 | 2013-03-31 | 28.13% | — |
Over the last five reported fiscal years, Phibro Animal Health's gross margin decreased from 32.10% to 30.85%, a change of −1.24 percentage points. The latest reported quarter, Q3 2026, shows 32.77%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phibro Animal Health filings at SEC.gov ↗